The Australian Commission on Safety and Quality in Health Care has published a report for clinicians summarising systematic reviews of medicinal cannabis evidence from 2020 to 2025.
The Department of Veterans' Affairs said in a 6 October statement responding to Four Corners' "Defenceless" that it has updated its Medicinal Cannabis Framework, including requiring initial GP consultations.
ECS Botanics Holdings told the ASX on 7 October 2026 it has entered a distribution and manufacturing agreement with Curaleaf Laboratories for ECS-branded medicinal cannabis in the UK.
The TGA said on 29 September it has published guidance explaining when news content about therapeutic goods may be regulated as advertising.
SBS News reported that Medicinal Organic Cannabis Australia removed a website statement about its products' approval status after the broadcaster's inquiries.
ABC News reported that a veteran was prescribed very high THC doses through DVA-funded for-profit providers, and that DVA has since tightened its rules.
Two of eleven. That's the entire bar for a diagnosis now making headlines as "cannabis addiction."
Roughly one in ten people who try cannabis goes on to develop cannabis use disorder (CUD). What separates that minority from everyone else who uses cannabis without it becoming a problem has never been well understood.
These changes do not liberate medicinal cannabis users; instead, they establish a digital surveillance framework that explicitly targets and bans people with chronic illnesses from driving.
A major Lancet Psychiatry meta-analysis on cannabinoids and mental health was reported accurately on some points, incompletely on others, and misleadingly on at least one finding that cuts against a well-established media narrative. Often, all three occurred in the same article.`
"Australia cannot refinery-build its way out of this crisis quickly enough. But it can grow its way toward a more resilient position — if it chooses to."
The endocannabinoid system plays a modulatory role in both pain processing and neurological function. It is altered in both Alzheimer's disease and chronic pain states, making it an area of active research interest.